Trials / Completed
CompletedNCT03192280
Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- Male
- Age
- 25 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This trial will test the feasibility of various imaging devices to detect local skin inflammation prior to clinical manifestation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Leukotriene B4 | Leukotriene B4 (LTB4) |
| DEVICE | FLIR One | Thermal imaging attachment to iPhone |
| DEVICE | SCIO | Handheld near-IR molecular spectroscopy device |
| DEVICE | MS Band 2 | Wearable "watch-like" device with multiple sensors |
| DEVICE | AGE reader | Portable bench top device for in-clinic near UV assessment |
| DEVICE | HSI prototype (PARC) hyper-spectral camera | Portable bench top device for in-clinic multispectral imaging |
| DEVICE | iPhone 7 | Smart phone |
Timeline
- Start date
- 2017-06-19
- Primary completion
- 2017-07-06
- Completion
- 2017-07-06
- First posted
- 2017-06-20
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03192280. Inclusion in this directory is not an endorsement.